Docs don't heed safety warning on BMS steroid

Despite a new label warning against epidural injections of Bristol-Myers Squibb's ($BMY) steroid Kenalog, doctors are still using the drug in that manner. "It is still being given in abundance," one pain-management doctor told Bloomberg, while safety experts say the FDA didn't do enough to highlight the label change. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.